PURPLE BIOTECH LTD's ticker is and the CUSIP is 74638P909. A total of 3 filers reported holding PURPLE BIOTECH LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $17 | -62.2% | 10,000 | -69.8% | 0.00% | – |
| Q4 2022 | $45 | -99.9% | 33,100 | +112.2% | 0.00% | – |
| Q3 2022 | $31,000 | +14.8% | 15,600 | +126.1% | 0.00% | – |
| Q1 2022 | $27,000 | -89.5% | 6,900 | -89.5% | 0.00% | – |
| Q4 2021 | $256,000 | +130.6% | 66,000 | +190.7% | 0.00% | – |
| Q3 2021 | $111,000 | +0.9% | 22,700 | +0.4% | 0.00% | – |
| Q2 2021 | $110,000 | +155.8% | 22,600 | +21423.8% | 0.00% | – |
| Q1 2021 | $43,000 | – | 105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 40,500 | $97,000 | 0.00% |